1991
DOI: 10.1097/00001721-199102000-00016
|View full text |Cite
|
Sign up to set email alerts
|

Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1991
1991
2008
2008

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Before 1990, two microsurgical thrombosis models were reported, 1112 and were applied by other authors. 13 " 15 These two models will be discussed in detail below. Briefly, there is no ideal thrombosis model for experimental microsurgical use.…”
mentioning
confidence: 99%
“…Before 1990, two microsurgical thrombosis models were reported, 1112 and were applied by other authors. 13 " 15 These two models will be discussed in detail below. Briefly, there is no ideal thrombosis model for experimental microsurgical use.…”
mentioning
confidence: 99%
“…No reversal agents exist for these agents, which can cause clinically significant bleeding. Hubbard et al 43 administered recombinant hirudin by intravenous pump for 5 to 7 days in a rabbit arterial inversion graft thrombosis model and found patency rates similar to those achieved using heparin. Other animal studies suggest that a single bolus of recombinant hirudin at the time of microvascular anastomosis results in patencies similar to those associated with heparin.…”
Section: Other Drugs Used In the Treatment Of Thrombosismentioning
confidence: 84%